Date post: | 14-Apr-2018 |
Category: |
Documents |
Upload: | saiibelieves |
View: | 223 times |
Download: | 0 times |
of 20
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
1/20
IDIOPATHIC
THROMBOCYTOPENIC
PURPURA (ITP)CASE ANALYSIS PRESENTATION
Sarah G. Lopez
Clinical Pharmacy Laboratory
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
2/20
Patient Information
LR, an 18 year old F was diagnosed with ITP.
The only indication present up until now are
bruises, red to violet spots in the skin,menorrhagia and rarely bleeding gums. As a
child the said signs appeared but the condition
was only diagnosed in her high school years.
There are no significant PMH, SH and FH
present. She had NKA.
Case Presentation by S.Lopez
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
3/20
Case Presentation by S.Lopez
Patient is currently taking prednisone 15mg
tablet PO BID (Available dose 30mg, broken
half), Vitamin C 500mg PO TID after meals,Fersulfate 500mg PO as needed during
menstruation period. Herbal Supplements,
Complete Phyto Energizer 500mg PO BID,
Power C plus 500mg PO BID 2xper meal and
Power greens 500mg PO BID 2x per meal.
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
4/20
General PE; well developed, VS; BP, temp. andRR normal, weight 50kg, height 142cm.
Extremities; petechia and purpura present whenPLT is low. Gets easily bruised. Blood testing,
PLT count, Bone marrow testing and X-ray was
done. Lowest PLT count recorded was 7x109.
Case Presentation by S.Lopez
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
5/20
Case Presentation by S.Lopez
Bone marrow testing showed normal results and
she has no other blood related condition. It was
done to rule out other conditions that manifest
thrombocytopenia. X-ray is done to monitor the
effects of prednisone in bones.
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
6/20
Platelets
Case Presentation by S.Lopez
Produced in blood cell formation in bone marrow
They circulate in the blood of mammals and are
involved in homeostatis, leading to the formationof blood clots. Low levels can lead to excessivebleeding, high levels leads to blood clots(thrombosis)
Normal level 150000-400000 mm3 is Life spanis 5 to 10 days
Platelets are destroyed by phagocytosis in thespleen
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
7/20
Discussion of Disease State
Idiopathic Thrombocytopenic Purpura (ITP) is an
acquired hemorrhagic disorder characterized by:
Thrombocytopenia - excessive destruction ofplatelets
Purpura - a discoloration caused by petechiae
beneath the skin
Normal bone marrow with normal or increased
number of immature platelets(megakaryocytes)
and eosinophils
Case Presentation by S.Lopez
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
8/20
Although the cause is unknown, it is believed tobe an autoimmune response to disease-related
antigens. It is the most frequentlyoccurring thrombocytopenia of childhood. The
greatest frequency of occurrence is between 0
and 10 years of age. The disease occurs in one
of two forms: an acute, self limiting course or
a chronic condition (greater than 6 months
duration).
Case Presentation by S.Lopez
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
9/20
Clinical Manifestation
Case Presentation by S.Lopez
Easy Bruising(purpura); Petechiae
Ecchymoses, most often over bony
prominences
Bleeding from mucous membrane
Epistaxis
Bleeding gums Internal hemorrhage: hematuria, hematemesis,
melena hemarthrosis, menorrhagia
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
10/20Purpura andPetechiae
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
11/20
Diagnostic Evaluation
Case Presentation by S.Lopez
In ITP, the PLT count is reduced to below 20,000
mm3; therefore, tests that depend on PLT
function such as bleeding time, and clotretraction are abnormal. Although there is no
definite test on which to establish a diagnosis
of ITP, several are usually performed to rule out
other disorders in which thrombocytopenia is a
manifestation, such as systemic lupus
erythematosus, lymphoma or leukemia.
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
12/20
Discussion of Drug Therapy
Case Presentation by S.Lopez
Prednisone
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
13/20
Case Presentation by S.Lopez
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
14/20
Project Description
Objective
Add your objective here
Results
Add your results here
Case Presentation by S.Lopez
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
15/20
Procedure/Methodology
Add your procedure here
Key assumptions
Add your assumptions here
Case Presentation by S.Lopez
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
16/20
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
17/20
Key Findings/Result 2
Project
Item 1
Item 2
Item 3
Item 4
Case Presentation by S.Lopez
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
18/20
Key Findings/Result 3
Run Number Description Result A Result B
1 Condition A True True
2 Condition B True False
3 Condition C False False
Case Presentation by S.Lopez
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
19/20
Conclusion
Add your conclusion here
Case Presentation by S.Lopez
7/30/2019 Idiopathic Thrombocytopenic Purpura (ITP)
20/20
Questions and Discussion
Case Presentation by S.Lopez